If you made any changes in Pure these will be visible here soon.

Personal profile


Career summary

Professor of Health Economics 1/8/16 -

Lead Health Economist for the Norwich Clinical Trials Unit 2013-2018

Reader in Health Economics University of East Anglia 01/08/12 - 31/7/16
Deputy Director of the East of England Research Design Service (RDS) (Norfolk and Suffolk region) 01/03/12 - 

Senior Lecturer in Health Economics, University of East Anglia 01/08/09 - 31/07/12

Lecturer in Health Economics University of East Anglia 01/08/07 - 31/07/09

ESRC/MRC PhD Studentship University of Nottingham 01/10/04 - 31/7/07

Research Associate MRC Institute of Hearing Research 01/10/01 - 30/9/04

Research Fellow University of York 01/11/98 - 30/9/01

Research Fellow University of Glamorgan 01/10/97 - 30/10/98

Professional Qualifications and professional memberships

Postgraduate Diploma in Higher Education Practice University of East Anglia Pass 2010

PhD. Health Economics University of Nottingham Pass 2007

MSc. Health Economics University of York Pass (with Magellan award) 1998

BA Economics and Sociology University of York 2 (i) 1996

Member of the UK Health Economics Study Group (HESG)

Key Research Interests

Application and development of the methods of economic evaluation

Research design (member of the East of England Research Design Service (RDS) and Norwich Clinical Trials Unit)

Selected research Grants

NIHR Research Design Service East of England (RDS EoE). The RDS EoE supports researchers to develop and design high quality research proposals for submission to NIHR funding programmes and other open, national, peer reviewed funding competitions, for health or social care research. It offers free and confidential advice to support health and social care researchers turn their ideas into strong research proposals.
Role: Deputy Director, site lead & co-applicant

The Norfolk Diabetes Prevention Study (NDPS). NDPS seeks to deliver a realistic diabetes prevention programme in the community. It assess whether diet and physical activity intervention, with and without the use of lay mentors with type 2 diabetes (T2DM), reduces the risk of transition to T2DM and is cost-effective, compared to usual care, in groups at high risk of Type 2 diabetes.
Role: Health economist & co-applicant

Dex-CSDH trial. A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma
Role: Health economist & co-applicant

RESCUE-ASDH. Randomised Evaluation of Surgery with Craniectomy versus craniotomy for adult head-injured patients Undergoing Evacuation of Acute Subdural Haematoma.
Role: Health economist & co-applicant

ARRISA-UK. At-Risk Registers Integrated into primary care to Stop Asthma crises in the UK: A pragmatic cluster randomised trial with nested economic and process evaluations examining the effects of integrating at-risk asthma registers into primary care with internet-based training and support.
Role: Health economist & co-applicant

PRODIGY. Prevention and treatment of long term social disability amongst young people with emerging severe mental illness: A randomised controlled trial
Role: Health economist & co-applicant

Selected papers
Quentin Summerfield & Garry Barton. Differential sensitivity of EQ-5D-3L, HUI2, HUI3, and SF-6D to changes in speech reception and annoyance due to tinnitus associated with unilateral cochlear implantation in adults with severe-profound hearing impairment. Quality of Life Research (in press).

Twigg MJ, Wright D, Barton G, Kirkdale CL, Thornley T. The Pharmacy Care Plan Service: service evaluation and estimate of cost-effectiveness. Research in Social and Administrative Pharmacy. (2018), https://doi.org/10.1016/j.sapharm.2018.03.062 http://www.rsap.org/article/S1551-7411(17)30838-0/pdf

Hunter SM, Johansen-berg H, Ward N, Kennedy N, Chandler E, Weir CJ, Rothwell J, Wing AM, Grey MJ, Barton G, Leavey NM, Havis C, Lemon R, Burridge J, Dymond A, Pomeroy VM. Functional Strength Training and Movement Performance Therapy for upper limb recovery early post-stroke – efficacy, neural correlates, predictive markers and cost-effectiveness: FAST-INdiCATE trial. Frontiers in Neurology (in press)

Crossman-Barnes CJ, Peel A, Fong-Soe-Khioe R, Sach T, Wilson A, Barton G. Economic evidence for non-pharmacological asthma management interventions: A systematic review. Allergy (in press)

Alava MH, Wailoo A, Grimm S, Pudney S, Gomes M, Sadique Z, Meads D, O’Dwyer J, Barton G, Irvine L. EQ-5D-5L versus 3L: the impact on cost-effectiveness in the UK. Value in Health. 2018; 21: 49-56.

Fowler D, French P, Banerjee R, Barton G, Berry C, Byrne R, Clarke T, Fraser R, Gee B, Greenwood K, Notley C, Parker S, Shepstone L, Wilson J, Yung AR. Hodgekins J. Prevention and treatment of long term social disability amongst young people with emerging severe mental illness (The PRODIGY Trial): Protocol for a definitive randomised controlled trial of Social Recovery Therapy. Trials. 18, 315.

Barton GR, Irvine L, Flather M, McCann GP, Curzen N, Gershlick AH, on behalf of the CvLPRIT trial investigators. Economic evaluation of complete revascularisation for patients with multi-vessel disease undergoing primary percutaneous coronary intervention. Value in Health 2017; 20: 745–751

Sackley CM, Walker MF, Burton C, Watkins C, Mant J, Roalfe AK, Wheatley K, Sheehan B, Sharp L, Stant K, Fletcher-Smith J, Steel K, Wilde K, Barton G, Irvine L, Peryer G, on behalf of the OTCH group. An Occupational Therapy intervention for residents with stroke-related disabilities in UK Care Homes (OTCH): cluster randomised controlled trial with economic evaluation. Health Technol Assess 2016;20(15)

Blyth A, Maskrey V, Notley C, Barton GR, Brown TJ, Aveyard P, Richard Holland, Max O Bachmann,
Stephen Sutton, Jo Leonardi-Bee, Thomas H Brandon, Fujian Song. Effectiveness and economic evaluation of self-help educational materials for the prevention of smoking relapse: randomised controlled trial. Health Technol Assess 2015;19(59). http://www.journalslibrary.nihr.ac.uk/hta/volume-19/issue-59

Twigg M Wright D, Barton G, Thornley T, Kerr C. The four or more medicines (FOMM) support service: results from an evaluation of a new community pharmacy service aimed at over-65s. International Journal of Pharmacy Practice. 2015; 23: 407–414. http://onlinelibrary.wiley.com/doi/10.1111/ijpp.12196/epdf
Logan PA, Armstrong S, Avery TJ, Barer D, Barton GR, Darby J, et al. Rehabilitation aimed at improving outdoor mobility for people after stroke: a multi-centre randomised controlled study (the Getting out of the House Study). Health Technol Assess 2014;18 (29)

M Goodall,  G Barton, P Bower, P Byrne, JE Cade, S Capewell, C Cleghorn, LA Kennedy, AM Martindale, C Roberts, S Woolf, MB Gabbay. Food for thought: pilot randomised controlled trial of Lay Health Trainers supporting dietary change to reduce cardiovascular disease in deprived communities. Journal of Public Health 2013; 36: 635-643. http://jpubhealth.oxfordjournals.org/content/36/4/635.full.pdf+html      

Barton GR, Fairall L, Bachmann MO, Uebel K, Timmerman V, Lombard C, Zwarenstein M. Cost-effectiveness of nurse-led versus doctor-led antiretroviral treatment in South Africa: Pragmatic cluster randomised trial. Tropical Medicine & International Health 2013; 18: 769-777.

Barton GR, Goodall M, Bower P, Woolf S, Capewell S, Gabbay MB. Increasing heart-health lifestyles in deprived communities: Economic evaluation of lay health trainers. Journal of Evaluation in Clinical Practice 2012; 18: 835-840. http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2753.2011.01686.x/epdf

Irvine L, Barton GR, Gasper A, Murray N, Clark A, Scarpello T, Sampson M. Cost effectiveness of a lifestyle intervention in preventing Type 2 diabetes: economic evaluation alongside a clinical trial. International Journal of Technology Assessment in Health Care 2011; 27: 275-282.

Barton GR, Sach T, Jenkinson C, Doherty M, Avery A, Muir KR. Lifestyle Interventions for Knee Pain: Cost-effectiveness analysis. British Medical Journal 2009;339:b2273.

Sach T, Barton GR, Jenkinson C, Doherty M, Avery A, Muir KR. Comparing cost-utility estimates: Does the choice of EQ-5D or SF-6D matter? Medical Care 2009; 47: 889-894.

Barton GR, Hodgekins J, Mugford M, Jones PB, Croudace T, Fowler D. Measuring the benefits of treatment for psychosis: The validity and responsiveness of the EQ-5D. British Journal of Psychiatry 2009;195:170-177.

Barton GR, Hodgekins J, Mugford M, Jones PB, Croudace T, Fowler D. Cognitive behaviour therapy for improving social recovery in psychosis: Cost-effectiveness analysis. Schizophrenia Research 2009; 112: 158-163.

Barton GR, Briggs A, Fenwick E. Optimal cost-effectiveness decisions: The role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI). Value in Health 2008; 11: 886-897.

Barton GR, Sach T, Avery AJ, Jenkinson C, Doherty M, Whynes DK, Muir KR. A comparison of the performance of the EQ-5D and SF-6D for patients aged ≥45 years. Health Economics 2008; 17: 815-832.




Teaching Interests

Lecturer/Module co-ordinator on the ‘Economic Evaluation’ module of the MSc. in Health Economics, School of Medicine, Health Policy & Practice, University of East Anglia.

Lecturer on the undergraduate MB/BS medical degree  programme, School of Medicine, Health Policy & Practice, University of East Anglia.


Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or